Cardior Pharmaceuticals‘ Lead Compound Demonstrates Improvement of Heart Function in Chronic Heart Failure Model
Safety and efficacy of CDR132L established in an in vivo model of chronic post-MI heart failure Study by international research team published in European Heart Journal Broad treatment potential for chronic heart failure Cardior Pharmaceuticals GmbH, a clinical-stage biotech company, Mehr



